Quadrivalent Market Size, Share, Analysis, Growth, Trends, Industry Report 2023-2032| AstraZeneca Plc., Serum Institute of India Pvt. Ltd., Sanofi S.A., GlaxoSmithKline Plc., CSL Limited, Bharat Biotech International Ltd.

Spread the love

The Quadrivalent Global Market Report 2023, provides comprehensive information on the quadrivalent market across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa for the 27 major global industries. The report covers a ten year historic period – 2010-2021, and a ten year forecast period – 2023-2032.

Learn More On The Quadrivalent Market’s Growth:

https://www.thebusinessresearchcompany.com/report/quadrivalent-global-market-report

The global quadrivalent market size is expected to grow from $7.30 billion in 2022 to $7.87 billion in 2023 at a compound annual growth rate (CAGR) of 7.8%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global quadrivalent market size is expected to grow to $10.58 billion in 2027 at a CAGR of 7.7%.

Get A Free Sample Of The Report (Includes Graphs And Tables):

https://www.thebusinessresearchcompany.com/sample_request?id=9335&type=smp

Product innovations are a key trend gaining popularity in the quadrivalent market. Major companies operating in the quadrivalent market are focused on developing innovative solutions to strengthen their position in the market. For instance, in September 2022, AstraZeneca, a UK-based pharmaceutical company, launched FluMist quadrivalent (Influenza Vaccination Live, Intranasal), a Food and Drug Administration (FDA)-approved nasal-spray flu vaccine for persons aged 2 to 49, that can be administered through a needle-free nasal spray. It is a live attenuated influenza vaccine (LAIV), available in trivalent or quadrivalent formulations, and is covered by most health insurance plans as well as the vaccines for children program.

The quadrivalent market is segmented:

1) By Type: Intradermal Shot, Intramuscular Injection, Nasal Spray

2) By Technology: Conjugated, Live, Inactivated, Recombinant, Toxoid, Other Technologies

3) By Disease: Cancer, Hepatitis, Pneumococcal disease, COVID-19, Influenza, Human Papilloma Virus, Meningococcal Disease, Polio, Rotavirus, Other Diseases

4) By Age Group: Pediatric, Adult

5) By Distribution Channel: Hospital And Pharmacy, Government Suppliers, Other Channels (NGOs)

North America was the largest region in the quadrivalent market in 2022.

The table of contents in TBRC’s quadrivalent market report includes:

1. Executive Summary

2. Quadrivalent Market Characteristics

3. Quadrivalent Market Trends And Strategies

4. Quadrivalent Market – Macro Economic Scenario

5. Quadrivalent Market Size And Growth

.

.

.

26. Africa Quadrivalent Market

27. Quadrivalent Market Competitive Landscape And Company Profiles

28. Key Mergers And Acquisitions In The Quadrivalent Market

29. Quadrivalent Market Future Outlook and Potential Analysis

30. Appendix

Top Major Players:

  • AstraZeneca Plc
  • Serum Institute of India Pvt. Ltd
  • Sanofi S.A
  • GlaxoSmithKline Plc
  • CSL Limited

Learn About Us:

The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries. Through the report businesses can gain a thorough understanding of the market’s size, growth rate, major drivers and leading players.

Contact Us:

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: [email protected]

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Twitter: https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Blog: https://blog.tbrc.info/

Healthcare Blog: https://healthcareresearchreports.com/

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model


Spread the love

About Top PR News

TopPRnews Leads Drives Search Engine Visibility For Your Press Release Content. Our Global Network Reaches Important Contacts, Media Partners And Websites And Journalists. Happy Postings! If You Have Any Queries Please Contact Official Mail At [[email protected]}

View all posts by Top PR News →